Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

Market Cap	5.22B -24.1%
Revenue (ttm)	2.82B -5.1%
Net Income	139.68M +27.5%
EPS	0.39 +36.3%
Shares Out	379.33M
PE Ratio	35.36
Forward PE	n/a
Dividend	0.25 (1.82%)
Ex-Dividend Date	May 15, 2026

Volume	14,466,942
Open	14.43
Previous Close	14.42
Day's Range	13.60 - 14.43
52-Week Range	11.58 - 22.47
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.

• Industry: Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 3,515
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300233

Financial Performance

In 2025, SHE:300233's revenue was 2.74 billion, a decrease of -18.87% compared to the previous year's 3.37 billion. Earnings were 44.19 million, a decrease of -77.55%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error